March 9 is World Kidney Day, a day aimed at raising awareness about the importance of the kidneys.
About 15% of adults in the U.S. are estimated to have chronic kidney disease — that’s about 37 million people.
What if those people could be treated with medication that could slow the progression of their disease, and help avoid the need for dialysis and kidney transplantation altogether?
Dr. Naim Issa, a Mayo Clinic transplant nephrologist says there is a class of medications to help people with chronic kidney disease that does just that. He says Mayo Clinic has been incorporating these medications to help patients for the last few years.
Most people don’t have symptoms of chronic kidney disease until it’s at an advanced stage.
“Early detection of chronic kidney disease may help us actually treat and prevent patients ahead of time before the need for dialysis or kidney transplantation,” says Dr. Issa.
He says a new class of drugs, SGLT2 inhibitors, is being called a game changer. The drugs were originally designed to treat diabetes — a main cause of chronic kidney disease.
Medicines in the SGLT2 inhibitor class include canagliflozin, dapagliflozin and empagliflozin.
“In large trials, we observed groundbreaking success with those medications in slowing down the progression of chronic kidney disease, to the extent of avoiding dialysis and the need for kidney transplantation,” Dr. Issa says.
The medications are used whether the patient is diabetic or not.
“They are actually game-changer medications that help us prevent the progression of chronic kidney disease,” says Dr. Issa.
You can help yourself by following a low-sodium, moderate-protein diet, avoiding smoking and getting plenty of exercise.
Dr. Issa says it is important that patients with chronic kidney disease work with their primary care physician and health care team to monitor and check blood pressure, urine analysis and bloodwork.
Related posts:
- Lifestyle changes can be critical for kidney transplant patients’ long-term survival
- Mayo Clinic Minute: What is chronic kidney disease?
- Diets higher in calcium and potassium may help prevent recurrent symptomatic kidney stones, Mayo Clinic study finds
The post Mayo Clinic Minute: Game-changing treatment for chronic kidney disease could slow down the progression of the disease appeared first on Mayo Clinic News Network.
Mayo Clinic, posted on SouthFloridaReporter.com
“Courtesy: Mayo Clinic News Network.”
Republished with permission
Disclaimer
The information contained in South Florida Reporter is for general information purposes only.
The South Florida Reporter assumes no responsibility for errors or omissions in the contents of the Service.
In no event shall the South Florida Reporter be liable for any special, direct, indirect, consequential, or incidental damages or any damages whatsoever, whether in an action of contract, negligence or other tort, arising out of or in connection with the use of the Service or the contents of the Service. The Company reserves the right to make additions, deletions, or modifications to the contents of the Service at any time without prior notice.
The Company does not warrant that the Service is free of viruses or other harmful components
This article originally appeared here and was republished with permission.
